BiotechTube
Home/i3 Pharmaceuticals/Sunil V. Sagi
SV

Sunil V. Sagi

EVP, Head of Scientific/Regulatory Affairs & QA/Compliance, Co-Founder

i3 Pharmaceuticals

Therapeutic Areas

Infectious DiseaseCardiologyCentral Nervous SystemOther Specialty

i3 Pharmaceuticals Pipeline

DrugIndicationPhase
Methscopolamine Bromide TabletsNot Specified (Typically GI/Respiratory)Approved
Clindamycin Phosphate Topical SolutionBacterial InfectionApproved
Posaconazole DR TabletsFungal InfectionApproved
Maraviroc TabletsHIV InfectionApproved
Guanfacine TabletsADHD / HypertensionApproved
Isosorbide Dinitrate/Hydralazine HCl TabletsHeart FailureApproved

Leadership Team at i3 Pharmaceuticals

DS
Douglas S. Hamilton
Chief Executive Officer, Co-Founder
RK
Ram K. Kallur
President, Head of Operations and Sourcing, Co-Founder
IP
Ishari P. Shrestha
EVP, Head of Research & Development, Executive Lead-HR, Co-Founder
View full i3 Pharmaceuticals profile